Fayetteville, NC4 Active Studies

Ankylosing Spondylitis Clinical Trials in Fayetteville, NC

Find 4 actively recruiting ankylosing spondylitis clinical trials in Fayetteville, NC. Connect with local research sites and explore new treatment options.

4
Active Trials
4
Sponsors
3,706
Enrolling

Recruiting Ankylosing Spondylitis Studies in Fayetteville

About Ankylosing Spondylitis Clinical Trials in Fayetteville

Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.

There are currently 4 ankylosing spondylitis clinical trials recruiting participants in Fayetteville, NC. These studies are seeking a combined 3,706 participants. Research is being sponsored by Bristol-Myers Squibb, Zimmer Biomet, Pfizer and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ankylosing Spondylitis Clinical Trials in Fayetteville — FAQ

Are there ankylosing spondylitis clinical trials in Fayetteville?

Yes, there are 4 ankylosing spondylitis clinical trials currently recruiting in Fayetteville, NC. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Fayetteville?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Fayetteville research site will contact you about next steps.

Are clinical trials in Fayetteville free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Fayetteville studies also compensate for your time and travel.

What ankylosing spondylitis treatments are being tested?

The 4 active trials in Fayetteville are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.

Data updated July 13, 2026 from ClinicalTrials.gov